Gibbs Wealth Management’s GSK GSK Stock Holding History

Gibbs Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$655K	Buy	+11,863	New	+$643K	0.09%	233

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Gibbs Wealth Management's GSK Position: Q1 2026 in Review

Gibbs Wealth Management opened a new position in GSK (GSK) in Q1 2026: 11,863 shares worth $655K. The stake represents 0.09% of the portfolio and ranks #233 among its holdings.

1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Gibbs Wealth Management held 11,863 shares of GSK worth $655K as of Q1 2026.
GSK was a new Gibbs Wealth Management position in Q1 2026.
GSK made up 0.09% of Gibbs Wealth Management's portfolio in Q1 2026, its #233 holding.
1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.